» Articles » PMID: 27455963

Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2016 Jul 27
PMID 27455963
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

In time-to-event analyses of observational studies of drug effectiveness, incorrect handling of the period between cohort entry and first treatment exposure during follow-up may result in immortal time bias. This bias can be eliminated by acknowledging a change in treatment exposure status with time-dependent analyses, such as fitting a time-dependent Cox model. The prescription time-distribution matching (PTDM) method has been proposed as a simpler approach for controlling immortal time bias. Using simulation studies and theoretical quantification of bias, we compared the performance of the PTDM approach with that of the time-dependent Cox model in the presence of immortal time. Both assessments revealed that the PTDM approach did not adequately address immortal time bias. Based on our simulation results, another recently proposed observational data analysis technique, the sequential Cox approach, was found to be more useful than the PTDM approach (Cox: bias = -0.002, mean squared error = 0.025; PTDM: bias = -1.411, mean squared error = 2.011). We applied these approaches to investigate the association of β-interferon treatment with delaying disability progression in a multiple sclerosis cohort in British Columbia, Canada (Long-Term Benefits and Adverse Effects of Beta-Interferon for Multiple Sclerosis (BeAMS) Study, 1995-2008).

Citing Articles

Evaluating the Role of High-Dimensional Proxy Data in Confounding Adjustment in Multiple Sclerosis Research: A Case Study.

Karim M, Hossain M, Ng H, Zhu F, Frank H, Tremlett H Pharmacoepidemiol Drug Saf. 2025; 34(2):e70112.

PMID: 39901338 PMC: 11791124. DOI: 10.1002/pds.70112.


Association of clinical signs of possible serious bacterial infections identified by community health workers with mortality of young infants in South Asia: a prospective, observational cohort study.

Darmstadt G, Ahmed S, Islam M, Abdalla S, El Arifeen S, Arvay M EClinicalMedicine. 2025; 80:103070.

PMID: 39896866 PMC: 11787667. DOI: 10.1016/j.eclinm.2025.103070.


Illustrating the structures of bias from immortal time using directed acyclic graphs.

Yang G, Burgess S, Schooling C Int J Epidemiol. 2025; 54(1).

PMID: 39777475 PMC: 11706530. DOI: 10.1093/ije/dyae176.


Association between statin use and dry eye disease in patients with hyperlipidemia: A population-based retrospective cohort study.

Wang Y, Liu S, Lin G, Huang E, Keller J, Wang L Clin Transl Sci. 2024; 17(10):e70039.

PMID: 39356083 PMC: 11445710. DOI: 10.1111/cts.70039.


Addressing immortal time bias in precision medicine: Practical guidance and methods development.

Weymann D, Krebs E, Regier D Health Serv Res. 2024; 60(1):e14376.

PMID: 39225454 PMC: 11782076. DOI: 10.1111/1475-6773.14376.


References
1.
Austin P, Platt R . Survivor treatment bias, treatment selection bias, and propensity scores in observational research. J Clin Epidemiol. 2010; 63(2):136-8. DOI: 10.1016/j.jclinepi.2009.05.009. View

2.
Sylvestre M, Abrahamowicz M . Comparison of algorithms to generate event times conditional on time-dependent covariates. Stat Med. 2007; 27(14):2618-34. DOI: 10.1002/sim.3092. View

3.
Shirani A, Zhao Y, Petkau J, Gustafson P, Karim M, Evans C . Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment. Biomed Res Int. 2015; 2015:451912. PMC: 4397470. DOI: 10.1155/2015/451912. View

4.
Buyse M, Piedbois P . On the relationship between response to treatment and survival time. Stat Med. 1996; 15(24):2797-812. DOI: 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V. View

5.
Ho P, Fihn S, Wang L, Bryson C, Lowy E, Maynard C . Clopidogrel and long-term outcomes after stent implantation for acute coronary syndrome. Am Heart J. 2007; 154(5):846-51. DOI: 10.1016/j.ahj.2007.08.028. View